Product Details:
Payment & Shipping Terms:
|
Keywords: | Cjc-1295 | Alias: | Peptide |
---|---|---|---|
Specification: | 5mg/vial 10vials/kit | Policy: | Reshipping Policy |
Description: | White Lyophilized Powder | Function: | Muscle Gaining |
Shipping Time: | 5-7 Working Days, Safe And Fast | Assy: | 99.6% |
High Light: | muscle growth peptides,fat loss peptides |
Cjc-1295 CAS 863288-34-0 Human Growth Peptides Cjc-1295 No Dac
CJC-1295 without DAC Descrption
CJC-1295 is a Long acting GHRH analog hormone-releasing hormone (GHRH), also known as hormone-releasing factor (GRF or GHRF) or somatocrinin, is a 44-amino acid peptide hormone produced in the hypothalamus by the arcuate nucleus. GHRH stimulates hormone (GH) secretion from the pituitary. GHRH is released in a pulsatile manner, stimulating pulsatile release of GH respectively.
CJC-1295 without DAC usage
Modified GRF 1-29 is also known as Mod GRF 1-29, but even more commonly known as CJC-1295 without DAC. It is a protein that is 29 amino acids long and it is a GHRH analogue. CJC-1295 without DAC acts on receptors at the pituitary gland to stimulate the release of Human Growth Hormone.
CJC-1295 without DAC could be referred to more properly as a second generation derivative of GHRH. GHRH is modified to create what is known as Releasing Factor (GRF) 1-29, also known as Sermorelin. GRF 1-29 is then further modified to create Mod GRF 1-29 which is CJC-1295 without DAC.
CJC-1295 DAC vs. CJC-1295 No DAC
CJC-1295 DAC and CJC-1295 (also known as Modified GRF 1-29) are both Growth Hormone Releasing Hormones (GHRH). Their action in the human body is identical but the difference between the two peptides are the span of the half-life. Modified GRF 1-29 and Sermorelin have a very short acting half-life of about 30 minutes, while CJC-1295 DAC has a half-life that can last up to approximately 8 days. Many a scientist have reported that the short half-life of Sermorelin and Modified GRF 1-29 is considered to be much more natural as they produce a short pulse of Human Growth Hormone.
CJC-1295 No DAC Cycle
Research study participants for often cycle doses 2-3 times per day (ex: before breakfast, before bed, and after exertion) for a period up to several weeks. These cycles, or pulses are meant to closely mimic natural secretion of GH. For CJC 1295, dosing is less frequent since the half-life with DAC is up to 8 days. Therefore, the cycle for CJC 1295 with DAC calls for once weekly injections that result in an overall increase of secretion of GH. At this point, research does not show any significant advantage for one cycle over the other, so it is a matter of personal preference.
Cjc-1295 CAS 863288-34-0 Human Growth Peptides Cjc-1295 Without DAC
Unit Size :2 mg/vial
Unit Quantity :1 Vial
CAS NO. :863288-34-0
Synonyms :CJC-1295 without DAC, CJC 1295 w/o DAC
Molecular Formula :C152H252N44O42
Molecular Weight :3367.97
Sequence :H-Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
Appearance :White Powder
Purity :99.19%
Identity (ESI-MS) :3367.97±3.0
Source :Chemical Synthesis
Storage :Lyophilized CJC-1295 W/O DAC is stable at room temperature for 90 days,however it should be stored in a freezer below -8C for any extended period of time. After reconstituting CJC-1295 W/O DAC should be refrigerated at temperatures not to exceed 36 F.
CJC-1295 without DAC Dosage
Mod GRF 1-29 is typically provided in vials containing 2 mg of lyophylized powder, though the amount can vary. The contents should be reconstituted by adding a convenient amount of sterile or bacteriostatic water. If for example 2 mL is chosen and the dosing of the vial is 2 mg, the resulting solution then has a concentration of 1 mg/mL, or 1000 mcg/mL.
At time of dosing, an insulin syringe is used to draw and then inject the desired amount. In the above example, a 100 mcg dose would require a volume of 0.10 mL, or "10 IU" as marked on an insulin syringe.
Injection may be subcutaneous, intramuscular, or intravenous, according to personal preference. If desired, peptide solutions from other vials, such as a vial of a GHRP product, may also be drawn into the same syringe. This reduces the total number of injections required.
I ordinarily recommend a dosage of 100 mcg Mod GRF at a time, simultaneous with injection of a GHRP. For maximum effect, dosing is preferably three times per day at times of low blood sugar, for example about 30 minutes before a meal, but where use is ongoing, a common use is once per day prior to sleep.
CJC-1295 without DAC Storage
Lyophilized MOD GRF 1-29 is stable at room temperature for 90 days, however it should be stored in a freezer below -8°C for any extended period of time. After reconstitution, may be stored for a maximum of 14 days in a refrigerator at 2°C - 8°C. Store vials in an upright position. Store MOD GRF-129 refrigerated between temperatures 2°C - 8°C. Keep in the outer carton in order to protect from light. For one month can be stored at room temperature.
Item | Specification | Result |
Appearance | White powder | Complies |
Identification | Positive | Complies |
Assay | 99.0% min | 99.08% |
Loss on Drying | 6.0%max. | 4.80% |
Mass Balance | 95.0~105.0% | Complies |
Acetate Content (HPIC) | 12.0%max. | 10.80% |
Peptide Content (N%) | 80.0%min. | 88.00% |
Amino Acid Composition | 10% of theoretical | Complies |
Single Impurity (HPLC) | 1.0%max. | 0.85% |
Contact Person: sales
Tel: +8613264710010